An apoA-I mimetic peptide containing a proline residue has greater in vivo HDL binding and anti-inflammatory ability than the 4F peptide
about
HDL apolipoprotein-related peptides in the treatment of atherosclerosis and other inflammatory disorders5A apolipoprotein mimetic peptide promotes cholesterol efflux and reduces atherosclerosis in mice.The apolipoprotein A-I mimetic peptide 4F prevents defects in vascular function in endotoxemic rats.Structure/function relationships of apolipoprotein a-I mimetic peptides: implications for antiatherogenic activities of high-density lipoprotein.Anti-inflammatory and cholesterol-reducing properties of apolipoprotein mimetics: a reviewIn vivo efficacy of HDL-like nanolipid particles containing multivalent peptide mimetics of apolipoprotein A-I.4F Peptide reduces nascent atherosclerosis and induces natural antibody production in apolipoprotein E-null mice.4F decreases IRF5 expression and activation in hearts of tight skin mice.An apolipoprotein A-I mimetic peptide designed with a reductionist approach stimulates reverse cholesterol transport and reduces atherosclerosis in mice.Biological properties of apolipoprotein a-I mimetic peptides.HDL mimetic peptide ATI-5261 forms an oligomeric assembly in solution that dissociates to monomers upon dilutionEnhancement by LDL of transfer of L-4F and oxidized lipids to HDL in C57BL/6J mice and human plasmaSidedness of interfacial arginine residues and anti-atherogenicity of apolipoprotein A-I mimetic peptidesThe N-Terminal GYPSY Motif Is Required for Pilin-Specific Sortase SrtC1 Functionality in Lactobacillus rhamnosus Strain GGSerum Amyloid A Facilitates Early Lesion Development in Ldlr-/- MiceHydrophobic amino acids in the hinge region of the 5A apolipoprotein mimetic peptide are essential for promoting cholesterol efflux by the ABCA1 transporter.Transintestinal transport of the anti-inflammatory drug 4F and the modulation of transintestinal cholesterol effluxMimicry of high-density lipoprotein: functional peptide-lipid nanoparticles based on multivalent peptide constructs.Structure and function of HDL mimetics.Molecules that mimic apolipoprotein A-I: potential agents for treating atherosclerosis.High-density lipoproteins and cardiovascular disease: 2010 update.High-density lipoprotein mimetics: promises and challenges.Reconstituted HDL elicits marked changes in plasma lipids following single-dose injection in C57Bl/6 mice.Anti-inflammatory peptides grab on to the whiskers of atherogenic oxidized lipids.An apoA-I mimetic peptibody generates HDL-like particles and increases alpha-1 HDL subfraction in mice.Mimetic peptides of human apoA-I helix 10 get together to lower lipids and ameliorate atherosclerosis: is the action in the gut?
P2860
Q27691344-2DF969A5-8D7F-44BF-975F-4EB234CEBF13Q34035255-30F8E48B-4F08-48EF-B693-821AEB8940D7Q34053131-A5A1B38D-7E8A-4701-B253-D1EAB4A14003Q34144449-A1B8A8BA-2CB8-4C10-A34D-63CF51B5AA86Q34238630-B785400F-5A42-4F92-A052-A3C6CA41DF61Q34238652-41588874-0307-4C1B-9158-A2CA655C048EQ34421798-9526E8B5-3041-4CEB-B6DA-6332CB735AB6Q34517543-CF058686-6B42-4CF2-A1CE-9695CE563A81Q34851167-D344D00D-16B1-482C-A93F-1AF58AB4E621Q34927488-A15C637D-DC96-4D70-9CA7-C6CCFA6A486AQ35001010-46A77AB1-5ECD-4604-BE84-642AC1EB735CQ35212906-9377B8E8-E580-414A-9ABE-38B40C9C4694Q35897017-53F2C9E5-1DD1-4A9A-ACE3-62797DD29C01Q35987291-2676AF1A-B9F6-4A02-9816-E1041D058356Q36168719-A6826F5C-4270-4707-B624-F55C6FBCBF8FQ36497600-98C86C16-4C67-487A-B7E0-2A801E2D9437Q37033119-283859AF-8323-4215-843C-C958FD8015B3Q37340299-E2D3374E-888F-43DA-9A36-2E82154400B5Q37553765-BFEDF73A-AF80-406D-A705-7843A56FEB8EQ37671683-3C2C6F8E-27BE-4031-BE0E-7C08BF3EE400Q37707412-788BFEDA-3925-4F74-9B16-390254EF2C38Q38650575-A4354883-7FD7-488E-B322-7155C047C37FQ39446360-46635469-131C-45FE-B53E-09BBE5B6BC02Q41974849-C65415C5-D9A2-42A6-82B8-2AEF4B0A007CQ42119788-5A4DF528-AEB4-4CF6-866E-5BDF880458F2Q42913663-4FA15E30-B549-40F0-BE34-37BFD23E2B43
P2860
An apoA-I mimetic peptide containing a proline residue has greater in vivo HDL binding and anti-inflammatory ability than the 4F peptide
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
An apoA-I mimetic peptide cont ...... ry ability than the 4F peptide
@en
An apoA-I mimetic peptide cont ...... y ability than the 4F peptide.
@nl
type
label
An apoA-I mimetic peptide cont ...... ry ability than the 4F peptide
@en
An apoA-I mimetic peptide cont ...... y ability than the 4F peptide.
@nl
prefLabel
An apoA-I mimetic peptide cont ...... ry ability than the 4F peptide
@en
An apoA-I mimetic peptide cont ...... y ability than the 4F peptide.
@nl
P2093
P2860
P1476
An apoA-I mimetic peptide cont ...... ry ability than the 4F peptide
@en
P2093
Catherine A Reardon
Geoffrey D Wool
Godfrey S Getz
Tomas Vaisar
P2860
P304
P356
10.1194/JLR.M900151-JLR200
P577
2009-05-11T00:00:00Z